ABANDON YOUR DOUBTS. NOT YOUR GOALS.

Stay the course

Uncertainty is a normal part of investing. But today, doubts arise at almost every turn, causing investors to question whether they have the right investment solutions.

It is natural to feel unsettled, but now is not the time to abandon long-term objectives. With the right perspective, we think it is possible to look past uncertainty and successfully navigate change.

Strategies to navigate uncertainty

Our investing approach is grounded in fundamental research. Based on insights gained from that research, we offer solutions that take three approaches to managing uncertainty.

Harness Disruption

Harness Disruption

We rely on deep analysis of companies, sectors and emerging trends to try to capitalise on the persistent forces disrupting the markets and the economy.

Learn More
Persure Income

Pursue Fixed Income

Uncertainty can shake any investor's confidence and lead to costly mistakes. To overcome uncertainty, pursue fixed income.

Learn More
Embrace Diversification

Embrace Diversification

We seek to provide distinct sources of return through asset classes and strategies that we feel are underappreciated or overlooked.

Learn More

An investment approach driven by bold thinking

We believe in confronting uncertainty head-on – not merely reacting to change but finding opportunity in it. Hear from our investment professionals on how they apply this approach in their fundamental research, part of an ethos we call
Knowledge Shared.

Breaking the link: GDP declines and default rates

Jenna Barnard and Nicholas Ware, Portfolio Managers in the Strategic Fixed Income Team, muse over how low corporate default rates may prove to be despite the pandemic-induced economic shock.

Read more

So… what about inflation?

John Pattullo, Co-Head of Strategic Fixed Income, shares his views on the most frequently asked question by clients these days: “what about inflation?”

Read more

What a return to ‘normal’ could mean for equities

In our ongoing video series on COVID-19, a discussion of the pandemic’s trajectory, vaccine development and investment considerations post-crisis.

Read more